Detalhe da pesquisa
1.
Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study.
Circulation
; 147(7): 532-545, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342348
2.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627035
3.
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
J Transl Med
; 21(1): 282, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101184
4.
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Histopathology
; 83(1): 91-103, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999648
5.
Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
Cancer
; 128(6): 1157-1161, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875102
6.
The role of depression and other psychological factors in work ability among breast cancer survivors in Australia.
Psychooncology
; 31(2): 167-175, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460129
7.
Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.
J Med Genet
; 58(12): 853-858, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168572
8.
Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk.
J Genet Couns
; 31(1): 120-129, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223688
9.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Mod Pathol
; 34(1): 194-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724153
10.
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
Genet Med
; 23(12): 2316-2323, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341522
11.
Uptake of polygenic risk information among women at increased risk of breast cancer.
Clin Genet
; 97(3): 492-501, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833054
12.
Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients- the BReast cancer EXercise InTervention (BREXIT) trial protocol.
BMC Cancer
; 20(1): 655, 2020 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32664946
13.
Therapeutic options for mucinous ovarian carcinoma.
Gynecol Oncol
; 156(3): 552-560, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902686
14.
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Gynecol Oncol
; 154(3): 531-538, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227223
15.
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Genet Med
; 19(4): 448-456, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27684037
16.
Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Gynecol Oncol
; 145(1): 130-136, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28162234
17.
Lynch syndrome and cervical cancer.
Int J Cancer
; 137(11): 2757-61, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26077226
18.
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
PLoS Genet
; 8(9): e1002894, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028338
19.
Impact of multidisciplinary team meetings on the management of patients with breast cancer in a large private healthcare facility.
Asia Pac J Clin Oncol
; 20(2): 285-291, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791022
20.
Cancer risks for MLH1 and MSH2 mutation carriers.
Hum Mutat
; 34(3): 490-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23255516